The FY2025 (Dec) proxy of Sera Prognostics names 18 peer companies for pay. Pay versus performance data of Sera Prognostics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Myriad Genetics | ||
| Personalis | ||
| Quantum-Si | ||
| Exagen | ||
| Biodesix | Not disclosed | Not disclosed |
| Cassava Sciences | Not disclosed | Not disclosed |
| GENELUX | Not disclosed | Not disclosed |
| Immunic | Not disclosed | Not disclosed |
| Insight Molecular Diagnostics | Not disclosed | Not disclosed |
| Lucid Diagnostics | Not disclosed | Not disclosed |
| Maxcyte | Not disclosed | Not disclosed |
| Neuronetics | Not disclosed | Not disclosed |
| Orchestra BioMed Holdings | Not disclosed | Not disclosed |
| Quanterix | Not disclosed | Not disclosed |
| Seer | Not disclosed | Not disclosed |
| Sight Sciences | Not disclosed | Not disclosed |
| Utah Medical Products | Not disclosed | Not disclosed |
| Verrica Pharmaceuticals | Not disclosed | Not disclosed |
18 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.